Stereotactic Ablative Radiation trial results published in Red Journal - ESTRO

Stereotactic Ablative Radiation trial results published in Red Journal – ESTRO

European Society for Radiotherapy & Oncology (ESTRO) posted the following on LinkedIn:

“Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial, published in the Red Journal.

Read it before your patients.”

Cancer research ESTRO European Society for Radiotherapy & Oncology oligoprogressive cancers OncoDaily Oncology randomized phase 2 stereotactic ablative radiation STOP trial